Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer

References

• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700–713.
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67.
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39:1010428317714626.
   Google Scholar
• Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537–3541.
   PubMed Web of Science ®Google Scholar
• Mu L, Yang F, Guo D, et al. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p. Bioengineered. 2020;11:472–483.
   PubMed Web of Science ®Google Scholar
• Tian B, Liu J. Resveratrol: a review of plant sources, synthesis, stability, modification and food application. J Sci Food Agric. 2020;100:1392–1404.
   PubMed Web of Science ®Google Scholar
• Rauf A, Imran M, Suleria HAR, et al. A comprehensive review of the health perspectives of resveratrol. Food Funct. 2017;8:4284–4305.
   PubMed Web of Science ®Google Scholar
• Elshaer M, Chen Y, Wang XJ, et al. Resveratrol: an overview of its anti-cancer mechanisms. Life Sci. 2018;207:340–349.
   PubMed Web of Science ®Google Scholar
• Berretta M, Bignucolo A, Di Francia R, et al. Resveratrol in cancer patients: from bench to bedside. Int J Mol Sci. 2020;21(8):2945.
   Web of Science ®Google Scholar
• Ashrafizadeh M, Rafiei H, Mohammadinejad R, et al. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021;21:66.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu D, Niu H, et al. Resveratrol reverses doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res. 2017;36(1):19.
   PubMed Web of Science ®Google Scholar
• Ren M, Zhou X, Gu M, et al. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress-mediated apoptosis and G2/M phase arrest. Oncol Rep. 2020;44:1605–1615.
   PubMed Web of Science ®Google Scholar
• Kim S, Kim W, Kim DH, et al. Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity. Arch Biochem Biophys. 2020;689:108413.
   PubMed Web of Science ®Google Scholar
• Khalid K, Tan X, Mohd Zaid HF, et al. Advanced in developmental organic and inorganic nanomaterial: a review. Bioengineered. 2020;11(1):328–355.
   PubMed Web of Science ®Google Scholar
• Jafari S, Derakhshankhah H, Alaei L, et al. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother. 2019;109:1100–1111.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313–327.
   PubMed Web of Science ®Google Scholar
• Bayir S, Barras A, Boukherroub R, et al. Mesoporous silica nanoparticles in recent photodynamic therapy applications. Photochem Photobiol Sci. 2018;17(11):1651–1674.
   PubMed Web of Science ®Google Scholar
• Fang J, Zhang S, Xue X, et al. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int J Nanomedicine. 2018;13:5113–5126.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang Z, Qiu Y, et al. Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma. J Drug Target. 2019;27(10):1135–1143.
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504–1534.
   PubMed Web of Science ®Google Scholar
• Pijuan J, Barceló C, Moreno DF, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.
   PubMed Web of Science ®Google Scholar
• Fu Y, Ye Y, Zhu G, et al. Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species. Mol Med Rep. 2021;23(3):170.
   Web of Science ®Google Scholar
• Wang LY, Zhao S, Lv GJ, et al. Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer. World J Clin Cases. 2020;8(12):2425–2437.
   PubMed Web of Science ®Google Scholar
• Hoang Thi TT, Cao VD, Nguyen TNQ, et al. Functionalized mesoporous silica nanoparticles and biomedical applications. Mater Sci Eng C Mater Biol Appl. 2019;99:631–656.
   PubMed Web of Science ®Google Scholar
• Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.
   Web of Science ®Google Scholar
• Venerito M, Link A, Rokkas T, et al. Gastric cancer - Clinical and epidemiological aspects. Helicobacter. 2016;21(Suppl 1):39–44.
   PubMedGoogle Scholar
• Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084.
   Web of Science ®Google Scholar
• Ko JH, Sethi G, Um JY, et al. The role of resveratrol in cancer therapy. Int J Mol Sci. 2017;18(12):2589.
   Web of Science ®Google Scholar
• Jiang Z, Chen K, Cheng L, et al. Resveratrol and cancer treatment: updates. Ann N Y Acad Sci. 2017;1403:59–69.
   PubMed Web of Science ®Google Scholar
• Xu QH, Xiao Y, Li XQ, et al. Resveratrol counteracts hypoxia-induced gastric cancer invasion and EMT through hedgehog pathway suppression. Anti Cancer Agents Med Chem. 2020;20:1105–1114.
   PubMed Web of Science ®Google Scholar
• Yang Z, Xie Q, Chen Z, et al. Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition. Exp Ther Med. 2019;17:1569–1578.
   PubMed Web of Science ®Google Scholar
• Huang XT, Li X, Xie ML, et al. Resveratrol: review on its discovery, anti-leukemia effects and pharmacokinetics. Chem Biol Interact. 2019;306:29–38.
   PubMed Web of Science ®Google Scholar
• Jain P, Hassan N, Iqbal Z, et al. Mesoporous silica nanoparticles: a versatile platform for biomedical applications. Recent Pat Drug Deliv Formul. 2018;12:228–237.
   PubMedGoogle Scholar
• Li T, Shi S, Goel S, et al. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Acta Biomater. 2019;89:1–13.
   PubMed Web of Science ®Google Scholar